Page 340 - IJB-10-4
P. 340

International Journal of Bioprinting                                   3D bioprinting of composite hydrogels






























            Figure 9. Cell morphology on GG (left) and GG–3PEI (right) 3D-bioprinted scaffolds after 5 days of culture. Abbreviations: GG, gellan gum; PEI,
            polyethyleneimine. Scale bars: 20 µm (left); 200 µm (right).


            3PEI bioink for ophthalmic delivery and corneal    Author contributions
            tissue regeneration. The bioprinted cornea had high
            transparency, stability, integrity, and shape fidelity, and it   Conceptualization: John P. Frampton, Ali Zamanian
                                                               Data curation: Armin Badri
            also ensured the growth and proliferation of a monolayer   Formal analysis: Negin Khoshnood, Armin Badri
            of corneal fibroblasts. Corneal fibroblasts spread on the   Funding acquisition: Ali Zamanian, John P. Frampton
            surface of the 3D-printed scaffold due to suitable surface   Investigation: Ali Zamanian, John P. Frampton,
            chemistry, i.e., containing bioactive and functional   Negin Khoshnood
            amine groups. Successful clinical application of this   Methodology: Negin Khoshnood, Armin Badri
            system will require in vivo testing, such as investigating   Project administration: Ali Zamanian
            the relationship between scaffold degradation and tissue   Resources: Ali Zamanian
            repair in animal models of corneal injury. In addition to   Supervision: Ali Zamanian, John P. Frampton
            establishing the biocompatibility of this novel ophthalmic   Validation: Ali Zamanian, John P. Frampton
            material, our data suggest that the rather low viscosity   Visualization: Negin Khoshnood, Armin Badri
            and  rapid  gelation  time  of  the  BSP-loaded  GG–3PEI   Writing – original draft: Negin Khoshnood
            3D-bioprinted corneal scaffold will enable controlled   Writing – review & editing: Ali Zamanian, John P. Frampton
            delivery of ocular drugs, such as anti-inflammatory
            agents, to aid in corneal repair.                  Ethics approval and consent to participate

            Acknowledgments                                    Not applicable.
            None.                                              Consent for publication

            Funding                                            Not applicable.

            This work was supported by funds from the Materials   Availability of data
            and Energy Research Center (MERC) (Grant No.
            14023050).                                         Data  are  available  from  the  corresponding  author  upon
                                                               reasonable request.
            Conflict of interest                               References

            The authors declare that they have no known competing
            financial interests or personal relationships that could have   1.   Dhar S, Mishra SK, Joshi A, et al. Evolving trends in corneal
            appeared to influence the work reported in this paper.  surgery. Delhi J Ophthalmol. 2023;33(4):280-289.


            Volume 10 Issue 4 (2024)                       332                                doi: 10.36922/ijb.3440
   335   336   337   338   339   340   341   342   343   344   345